Change search
ReferencesLink to record
Permanent link

Direct link
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
Umeå University, Faculty of Medicine, Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2004 (English)In: The Journal of clinical endocrinology and metabolism, ISSN 0021-972X, Vol. 89, no 5, 2078-84 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 89, no 5, 2078-84 p.
Keyword [en]
Adamantane/adverse effects/analogs & derivatives/*therapeutic use, Aged, Antigens; CD26/*drug effects, Blood Glucose/*metabolism, Body Weight/drug effects, Circadian Rhythm, Diabetes Mellitus; Type 2/*blood/*drug therapy, Eating, Enzyme Inhibitors/adverse effects/*therapeutic use, Female, Glucagon/*blood, Hemoglobin A; Glycosylated/metabolism, Humans, Insulin/*blood, Lipids/blood, Male, Middle Aged, Pyrrolidines/adverse effects/*therapeutic use
URN: urn:nbn:se:umu:diva-12907PubMedID: 15126524OAI: diva2:152578
Available from: 2007-04-24 Created: 2007-04-24 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 59 hits
ReferencesLink to record
Permanent link

Direct link